Si-Bone (SIBN) Cash from Investing Activities (2017 - 2026)
Si-Bone (SIBN) recorded quarterly Cash from Investing Activities of -$6.2 million in Q1 2026, down 147.84% quarter-over-quarter from $13.0 million in Q4 2025, and down 158.63% on a YoY basis from $10.6 million in Q1 2025.
Si-Bone (SIBN) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Si-Bone's Cash from Investing Activities history runs 10 years deep, the most recent figure standing at -$6.2 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 158.63% year-over-year to -$6.2 million; the TTM figure through Mar 2026 stood at -$12.7 million (down 175.13% YoY), while the FY2025 annual figure was $4.2 million, down 67.04% from the prior year.
- Cash from Investing Activities was -$6.2 million for Q1 2026 at Si-Bone, down from $13.0 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $13.0 million in Q4 2025 to a low of -$54.9 million in Q3 2023.
- Historically, Cash from Investing Activities has averaged -$3.1 million across 5 years, with a median of $2.3 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities tumbled 21349.44% in 2023, then soared 200.35% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at $89000.0 in 2022, then sank by 21349.44% to -$18.9 million in 2023, then soared by 122.93% to $4.3 million in 2024, then jumped by 200.35% to $13.0 million in 2025, then sank by 147.84% to -$6.2 million in 2026.
- The last three Cash from Investing Activities figures came in at -$6.2 million (Q1 2026), $13.0 million (Q4 2025), and -$10.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Si-Bone | 696.98 Mn | 556.86 Mn | 41.94 Mn | -6.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.23 Mn |
| Mar 31, 2026 | -6.23 Mn |
| Dec 31, 2025 | 13.03 Mn |
| Dec 31, 2025 | 13.03 Mn |
| Sep 30, 2025 | -10.03 Mn |
| Sep 30, 2025 | -10.03 Mn |
| Jun 30, 2025 | -9.47 Mn |
| Jun 30, 2025 | -9.47 Mn |
| Mar 31, 2025 | 10.63 Mn |
| Mar 31, 2025 | 10.63 Mn |
| Dec 31, 2024 | 4.34 Mn |
| Dec 31, 2024 | 4.34 Mn |
| Sep 30, 2024 | 3.77 Mn |
| Sep 30, 2024 | 3.77 Mn |
| Jun 30, 2024 | -1.83 Mn |
| Jun 30, 2024 | -1.83 Mn |
| Mar 31, 2024 | 6.35 Mn |
| Mar 31, 2024 | 6.35 Mn |
| Dec 31, 2023 | -18.91 Mn |
| Dec 31, 2023 | -18.91 Mn |